Form 4: iCAD Inc. Director Andy Sassine Acquires Stock Options in Lieu of Cash Fees
SEC Form 4 Filing
Director Andy Sassine acquired 25,259 stock options in iCAD Inc. in lieu of quarterly cash director fees on April 1, 2024.
Summary
- On April 1, 2024, Andy Sassine, a director of iCAD Inc., acquired 25,259 stock options.
- These options were granted in lieu of quarterly cash director fees.
- The exercise price of the options is $1.52.
- The options are immediately exercisable and expire on April 1, 2034.
- The underlying security is common stock, with 25,259 shares.
- Following the transaction, Sassine directly owns 25,259 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The grant of options in lieu of cash is slightly positive as it preserves cash.
Positives
- The acquisition of stock options by a director aligns their interests with those of the shareholders.
- Granting options in lieu of cash fees conserves the company's cash resources.
Industry Context
This type of equity compensation is common for directors, aligning their interests with shareholders and conserving company cash.
Comparison to Industry Standards
- Granting stock options to directors in lieu of cash compensation is a fairly standard practice among publicly traded companies, particularly smaller ones, to conserve cash.
- The specific number of options granted and the exercise price would need to be compared to similar companies in the medical technology sector to assess whether the grant is within industry norms.
- Companies like Hologic, Inc. and Intuitive Surgical, Inc. are larger players in the medical device industry and their director compensation packages could serve as benchmarks, although direct comparisons should account for company size and performance.
Related Party Transactions
- The grant of stock options to Andy Sassine, a director, is a related party transaction.
Stakeholder Impact
- Shareholders may view the grant of options positively as it aligns director interests with theirs.
- The company benefits from conserving cash by granting options instead of cash fees.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of the transaction: Andy Sassine acquired stock options. |
| 04/01/2024 | Date the stock options are immediately exercisable. |
| 04/01/2034 | Expiration date of the stock options. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.